COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03227263
Brief Title: BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). (BABH)

First Submitted : July 21, 2017
First Submitted that Met QC Criteria : July 21, 2017
First Posted : July 24, 2017

Last Update Submitted that Met QC Criteria : December 18, 2019
Last Update Posted : December 19, 2019